Doctor Care Anywhere Group Plc

DOC.ASX

Health Care

Health Care Services through virtual medical general practitioner services and internet hospital

Market Data

Price

$0.128

-0.1%
Market Cap

$49.5M

P/E Ratio

34.2x

EPS

$0.004

Div. Yield

0.00%

52-Week Change

-0.1%

Latest Earnings

Preliminary Final Report

25 February 2026

Revenue
$38.00
+6.5% YoY
NPAT
$2.80
+230.2% YoY
EPS
$0.00

Doctor Care Anywhere delivered a significant turnaround in FY25, achieving its first full-year profitability with underlying EBITDA of £5.3m (13.9% margin) and net profit of £1.2m versus a £6.3m loss in FY24, driven by 6.5% underlying revenue growth, 5.2ppt margin expansion to 43.5%, and successful cost restructuring. The company returned to consultation growth of 3.4% in H2 and generated strong cash of £2.2m, positioning itself for 15% EBITDA margins and revenue doubling over 3-5 years. Key points: Historic first full-year profitability: £1.2m net profit and 0.31p EPS versus £6.3m loss in FY24, representing a turning point for the business; Underlying EBITDA surged 7,643% to £5.3m (13.9% margin) with 5.2ppt margin expansion driven by price increases, clinical mix, and operational efficiencies; Consultation growth returned in H2 with 3.4% growth, outpacing 2024 volumes every month since May, signaling successful product diversification

Recent Announcements

25 Feb 2026 Actual Results Positive

Preliminary Final Report

Doctor Care Anywhere delivered a significant turnaround in FY25, achieving its first full-year profitability with underlying EBITDA of £5.3m (13.9% margin) and net profit of £1.2m versus a £6.3m loss in FY24, driven by 6.5% underlying revenue growth, 5.2ppt margin expansion to 43.5%, and successful cost restructuring. The company returned to consultation growth of 3.4% in H2 and generated strong cash of £2.2m, positioning itself for 15% EBITDA margins and revenue doubling over 3-5 years. Key points: Historic first full-year profitability: £1.2m net profit and 0.31p EPS versus £6.3m loss in FY24, representing a turning point for the business; Underlying EBITDA surged 7,643% to £5.3m (13.9% margin) with 5.2ppt margin expansion driven by price increases, clinical mix, and operational efficiencies; Consultation growth returned in H2 with 3.4% growth, outpacing 2024 volumes every month since May, signaling successful product diversification

19 Feb 2026 Date Announcement Neutral

Preliminary Final Report Release Date Announcement

Doctor Care Anywhere Group PLC (ASX:DOC) announced it will release its Appendix 4E preliminary final report for the year ended 31 December 2025 on Wednesday 25 February 2026.

Get real-time alerts for DOC

Receive AI-powered earnings summaries and instant notifications when Doctor Care Anywhere Group Plc releases results.

Register Free